RHPS has just mentioned the above in an e-mail, they have gone up 240% today - started at 0.60 and finished up at 1.65. Look to be quite interesting.

Taken a punt in this, pure gamble....not sure at all....but will be patient (no pun), until decent profit emerges.....

Could easily go to 5p......volatile....

Kudos to Gibby who quite accurately predicted the SP finishing over 3p today :p

Well done all those in at low levels
D

Small profit showing......will this turn out to be a star ?.....could go much further on monday !...

3m's your luck might be in......keep watching.

Who knows, throw a coin up in the air as they say - better than nothing though, keep everything crossed this weekend and see what happens. Balerboy I sold PVC - lost 52.50, I spied my chance and sold for 0.52 - watch this space they will go up now haah!! I'm not bothered I'm out. My friend made a few bob this morning with sar which I am more than pleased for her.

Have a good weekend all.

Sorry I meant PYC - did you get out ballerboy?

missed it, had to go out.....sods law..lol

I really hope that my luck is in with Sar BECAUSE IF EVER I MAKE A PROFIT

we'll meet in yr local.....

You might have a long way to travel and your pouch might not get on with mine oh dear too many gins uuuupppppppsssssssssssss.

Drug group Sareum soars on cancer inhibitor news
Sareum, an Aim-listed drug discovery company, has more than doubled after positive results from a pre-clinical trial of its cancer treatment.
The company's Chk1 inhibitor, when combined with chemotherapeutic drugs, showed a more than two fold reduction in cancer growth rates, compared to using the chemotherapeutic alone. The cancer growth inhibitor was developed in collaboration with Cancer Research Technology and the Institute of Cancer Research. Sareum chief executive Tim Mitchell said the studies demonstrated the efficacy of its compounds in several cancer models, and trials on other models were continuing. These are still early stages - there is no licensing agreement as yet for example - but Mitchell said:
We believe the results from the recently conducted studies will significantly enhance the licensing package and assist the collaboration in selecting the best compound for development into a clinical trials candidate.
Early stage or not, the market likes the latest developments, and Sareum's shares have jumped 1.34p to 2.39p.


http://www.guardian.co.uk/business/marketforceslive/2011/mar/04/sareum-soars-cancer-inhibitor


http://www.growthcompany.co.uk/news/1607738/sareum-announce-latest-update.thtml

In the know: Capita, Sareum Holdings

* The Times
* Published: 05 March 2011
* Markets

...sector business. . Tiddler to watch Shares in Sareum Holdings more than doubled, rising 1p to 2p, after the drug discovery company said that its cancer growth inhibitor...

I think the word flat was a typo..lol some coverage today though...

MARKET REPORT by GEOFF FOSTER:

Cancer drug discovery company Sareum was flat at 2.38p after revealing that its cancer growth inhibitor therapy had shown positive results in pre-clinical trials. Apparently, when its inhibitor was combined with chemotherapeutic drugs it had led to a greater reduction in the growth rate of colon cancer than did the drugs alone.

Read more: http://www.dailymail.co.uk/money/article-1363155/MARKET-REPORT-GEOFF-FOSTER-ITV-tunes-Footsie-elite.html#ixzz1Fi3ymTMp

double post.

It could do what Provexis sp did a few years ago, next week, (soaring to 10p) or so because this is a major result by this small company !.

Certainly a good result at last for this little bioco. I held years ago but then sold as it seemed to be running out of cash. P'raps time to get back in now?

I like this post from another bb.... Opinion: Strong Buy
Price: 2.38
My Views on Sareum..in a nutshellToday 02:27

(a) It is currently oversold after spike in mid Feb and the market cap is still low at 28-32 million ...say compared to Phytopharm with a single 43% Phase 2 cure for Parkinsons and capitalised at a couple of million more

(b) The trial results are exceptional - 1 in 100 potentially successful drugs fails to get to pre-clinicals...the fallout for Phase 1-3 is statistically less and usually the pre-clinical gives a hint of failure eg 20% efficicacy..here we have a PRE CLINICAL 100% cure, see (f) for the reason why... which is the real reason for us all to stay invested

(c) Cancer cures is a potentially multibillion market

Now for the biggies

(d) despite the buzz on here probably no more than 30,000 people in a world of 7 billion are FULLY aware of the signifigance of their methodology and the outcome of the trials.. as the news spreads the investment will increase dramatically

(e) The company has no major institutional holders...with its sudden burst in size all the AIM / small cap funds need to buy some and they should by now all be tightly held by PI's who have seen 100-200% gains and haven't taken thethe profit REASON they have reached the logical conclusion that this is a multibagger like no other.... so demand will exceed supply and the price must therefore rise almost inexorably....well to the point where everyone can see the emperor is bare....this could after all be the South Sea Bubble of the 21st century!!

(e) The company is not a one trick pony..the second RNS confirms the power of the STIL platform....from the identification of a problem to tackle and the formulation of a strategy to preclinical success takes on average 6-8 years....SAR floated in late 2004 so 2011-3 is the period when the initial products will come home to roost...this is the first two of the initial products and there is a pipeline of other targets which they have started to tackle over the last 6 years which we are not including in the valuation

(f) The biggest asset the company has is the technology to identify the disease cause and the molecule to solve it...this can be rolled out for hundreds of diseases....the building of the magic bullet and the testing of it are time consuming but relatively simple....so in effect YOU ARE NOT investing in a cure for myeloid luekemia but rather in a cloud factory to produce the CURES to many diseases.....and healthcare is the only part of the economy in the UK or the world which is not being cut back at the moment

IN SUMMARY SAREUM's DIAGNOSIS AND DESIGN PROCEDURE IS BIGGER THAN E-PROCUREMENT / RDIF / ALTERNATIVE ENERGY and SCARCE MINERAL RESOURCES PUT TOGETHER.

DYOR

Going by this : 5 to 10p next week ?....I'd like to think so, but surely a rise by a penny is in the running on monday .....hope so...

Is Tabby in these? We are sunk if he is! ;o)

Nah! Only joking Tabs! :0)

SAR has a very good chance of strong interest from potential licencees now. Nothing guaranteed as always with research companies like this, but it cannot be ruled out as a potential 10+ bagger from here on.